IMA901 in Advanced Renal Cell Carcinoma Patients With Measurable Disease

Clinical trial NCT00523159 · COMPLETED

Trial details

NCT number: NCT00523159
Sponsor: Immatics Biotechnologies GmbH
Status: COMPLETED
Phase: Phase 2
Study type: INTERVENTIONAL

Renal Cell Carcinoma

Start date: 2007-05-01
Primary completion: 2009-08-01
Enrollment: 68

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.